The Apraxia of Speech Rating Scale: Reliability, Validity, and Utility

The purpose of this study was to examine the interrater reliability and validity of the Apraxia of Speech Rating Scale (ASRS-3.5) as an index of the presence and severity of apraxia of speech (AOS) and the prominence of several of its important features. Interrater reliability was assessed for 27 pa...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of speech-language pathology Vol. 32; no. 2; pp. 469 - 491
Main Authors Duffy, Joseph R., Martin, Peter R., Clark, Heather M., Utianski, Rene L., Strand, Edythe A., Whitwell, Jennifer L., Josephs, Keith A.
Format Journal Article
LanguageEnglish
Published United States American Speech-Language-Hearing Association 01.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The purpose of this study was to examine the interrater reliability and validity of the Apraxia of Speech Rating Scale (ASRS-3.5) as an index of the presence and severity of apraxia of speech (AOS) and the prominence of several of its important features. Interrater reliability was assessed for 27 participants. Validity was examined in a cohort of 308 participants (120 with and 188 without progressive AOS) through item analysis; item-Total score correlations; correlations among ASRS Total score and component subscores and independent clinical ratings of AOS, dysarthria and aphasia severity, intelligibility, and articulatory errors, as well as years postonset and age; and regression models assessing item and Total score prediction of AOS presence. Interrater reliability was good or excellent for most items and excellent for the Total score. Item and Total score analyses revealed good separation of participants with versus without AOS. Inter-item and item-Total score correlations were generally moderately high as were correlations between the ASRS Total score and independent ratings of AOS severity, intelligibility, and articulatory errors. The Total score was not meaningfully correlated with ratings of aphasia and dysarthria severity, years postonset, or age. Total scores below 7 and above 10 revealed excellent diagnostic sensitivity and specificity for AOS. The presence of eight or more abnormal features was also highly predictive of AOS presence. The ASRS-3.5 is a reliable and valid scale for identifying the presence and severity of AOS and its predominant features. It has excellent sensitivity to AOS presence and excellent specificity relative to aphasia and dysarthria in patients with neurodegenerative disease. https://doi.org/10.23641/asha.21817584.
AbstractList Purpose: The purpose of this study was to examine the interrater reliability and validity of the Apraxia of Speech Rating Scale (ASRS-3.5) as an index of the presence and severity of apraxia of speech (AOS) and the prominence of several of its important features. Method: Interrater reliability was assessed for 27 participants. Validity was examined in a cohort of 308 participants (120 with and 188 without progressive AOS) through item analysis; item-Total score correlations; correlations among ASRS Total score and component subscores and independent clinical ratings of AOS, dysarthria and aphasia severity, intelligibility, and articulatory errors, as well as years postonset and age; and regression models assessing item and Total score prediction of AOS presence. Results: Interrater reliability was good or excellent for most items and excellent for the Total score. Item and Total score analyses revealed good separation of participants with versus without AOS. Inter-item and item-Total score correlations were generally moderately high as were correlations between the ASRS Total score and independent ratings of AOS severity, intelligibility, and articulatory errors. The Total score was not meaningfully correlated with ratings of aphasia and dysarthria severity, years postonset, or age. Total scores below 7 and above 10 revealed excellent diagnostic sensitivity and specificity for AOS. The presence of eight or more abnormal features was also highly predictive of AOS presence. Conclusions: The ASRS-3.5 is a reliable and valid scale for identifying the presence and severity of AOS and its predominant features. It has excellent sensitivity to AOS presence and excellent specificity relative to aphasia and dysarthria in patients with neurodegenerative disease. Supplemental Material:
The purpose of this study was to examine the interrater reliability and validity of the Apraxia of Speech Rating Scale (ASRS-3.5) as an index of the presence and severity of apraxia of speech (AOS) and the prominence of several of its important features.PURPOSEThe purpose of this study was to examine the interrater reliability and validity of the Apraxia of Speech Rating Scale (ASRS-3.5) as an index of the presence and severity of apraxia of speech (AOS) and the prominence of several of its important features.Interrater reliability was assessed for 27 participants. Validity was examined in a cohort of 308 participants (120 with and 188 without progressive AOS) through item analysis; item-Total score correlations; correlations among ASRS Total score and component subscores and independent clinical ratings of AOS, dysarthria and aphasia severity, intelligibility, and articulatory errors, as well as years postonset and age; and regression models assessing item and Total score prediction of AOS presence.METHODInterrater reliability was assessed for 27 participants. Validity was examined in a cohort of 308 participants (120 with and 188 without progressive AOS) through item analysis; item-Total score correlations; correlations among ASRS Total score and component subscores and independent clinical ratings of AOS, dysarthria and aphasia severity, intelligibility, and articulatory errors, as well as years postonset and age; and regression models assessing item and Total score prediction of AOS presence.Interrater reliability was good or excellent for most items and excellent for the Total score. Item and Total score analyses revealed good separation of participants with versus without AOS. Inter-item and item-Total score correlations were generally moderately high as were correlations between the ASRS Total score and independent ratings of AOS severity, intelligibility, and articulatory errors. The Total score was not meaningfully correlated with ratings of aphasia and dysarthria severity, years postonset, or age. Total scores below 7 and above 10 revealed excellent diagnostic sensitivity and specificity for AOS. The presence of eight or more abnormal features was also highly predictive of AOS presence.RESULTSInterrater reliability was good or excellent for most items and excellent for the Total score. Item and Total score analyses revealed good separation of participants with versus without AOS. Inter-item and item-Total score correlations were generally moderately high as were correlations between the ASRS Total score and independent ratings of AOS severity, intelligibility, and articulatory errors. The Total score was not meaningfully correlated with ratings of aphasia and dysarthria severity, years postonset, or age. Total scores below 7 and above 10 revealed excellent diagnostic sensitivity and specificity for AOS. The presence of eight or more abnormal features was also highly predictive of AOS presence.The ASRS-3.5 is a reliable and valid scale for identifying the presence and severity of AOS and its predominant features. It has excellent sensitivity to AOS presence and excellent specificity relative to aphasia and dysarthria in patients with neurodegenerative disease.CONCLUSIONSThe ASRS-3.5 is a reliable and valid scale for identifying the presence and severity of AOS and its predominant features. It has excellent sensitivity to AOS presence and excellent specificity relative to aphasia and dysarthria in patients with neurodegenerative disease.https://doi.org/10.23641/asha.21817584.SUPPLEMENTAL MATERIALhttps://doi.org/10.23641/asha.21817584.
Supplemental Material: https://doi.org/10.23641/asha.21817584
The purpose of this study was to examine the interrater reliability and validity of the Apraxia of Speech Rating Scale (ASRS-3.5) as an index of the presence and severity of apraxia of speech (AOS) and the prominence of several of its important features. Interrater reliability was assessed for 27 participants. Validity was examined in a cohort of 308 participants (120 with and 188 without progressive AOS) through item analysis; item-Total score correlations; correlations among ASRS Total score and component subscores and independent clinical ratings of AOS, dysarthria and aphasia severity, intelligibility, and articulatory errors, as well as years postonset and age; and regression models assessing item and Total score prediction of AOS presence. Interrater reliability was good or excellent for most items and excellent for the Total score. Item and Total score analyses revealed good separation of participants with versus without AOS. Inter-item and item-Total score correlations were generally moderately high as were correlations between the ASRS Total score and independent ratings of AOS severity, intelligibility, and articulatory errors. The Total score was not meaningfully correlated with ratings of aphasia and dysarthria severity, years postonset, or age. Total scores below 7 and above 10 revealed excellent diagnostic sensitivity and specificity for AOS. The presence of eight or more abnormal features was also highly predictive of AOS presence. The ASRS-3.5 is a reliable and valid scale for identifying the presence and severity of AOS and its predominant features. It has excellent sensitivity to AOS presence and excellent specificity relative to aphasia and dysarthria in patients with neurodegenerative disease. https://doi.org/10.23641/asha.21817584.
Audience Academic
Author Strand, Edythe A.
Clark, Heather M.
Martin, Peter R.
Duffy, Joseph R.
Whitwell, Jennifer L.
Josephs, Keith A.
Utianski, Rene L.
AuthorAffiliation d Department of Radiology, Mayo Clinic, Rochester, MN
b Department of Quantitative Health Sciences (Biostatistics), Mayo Clinic, Rochester, MN
c Department of Speech & Hearing Sciences, University of Washington, Seattle
a Department of Neurology, Mayo Clinic, Rochester, MN
AuthorAffiliation_xml – name: c Department of Speech & Hearing Sciences, University of Washington, Seattle
– name: b Department of Quantitative Health Sciences (Biostatistics), Mayo Clinic, Rochester, MN
– name: a Department of Neurology, Mayo Clinic, Rochester, MN
– name: d Department of Radiology, Mayo Clinic, Rochester, MN
Author_xml – sequence: 1
  givenname: Joseph R.
  orcidid: 0000-0001-8206-3432
  surname: Duffy
  fullname: Duffy, Joseph R.
– sequence: 2
  givenname: Peter R.
  surname: Martin
  fullname: Martin, Peter R.
– sequence: 3
  givenname: Heather M.
  orcidid: 0000-0001-9697-0084
  surname: Clark
  fullname: Clark, Heather M.
– sequence: 4
  givenname: Rene L.
  orcidid: 0000-0001-9519-1302
  surname: Utianski
  fullname: Utianski, Rene L.
– sequence: 5
  givenname: Edythe A.
  surname: Strand
  fullname: Strand, Edythe A.
– sequence: 6
  givenname: Jennifer L.
  orcidid: 0000-0002-8074-6587
  surname: Whitwell
  fullname: Whitwell, Jennifer L.
– sequence: 7
  givenname: Keith A.
  orcidid: 0000-0003-2930-8634
  surname: Josephs
  fullname: Josephs, Keith A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36630926$$D View this record in MEDLINE/PubMed
BookMark eNp9kl1rFDEUhoNU7If-AkEGhOKF0-ZrMjPelKW0frCgdFtvQ5I5sxPJJuskK-2_N7vb1q6I5CKHk-d9yZucQ7TngweEXhN8QjDnpxRTKidfZtNvJaUlxoQ3z9ABqaqmbAnBe7nGucZM4H10GOMPnBlC6Qu0z4RguKXiAF1eD1BMlqO6taoIfTFbApihuFLJ-nkxM8rBh-IKnFXaOpvu3hfflbPdplK-K27Spv0SPe-Vi_Dqfj9CN5cX1-efyunXj5_PJ9PSVDVOpWAt0LbSWnNd98CFAEV5U3EtNO6E7jFucg7RG8ZJ06haaai4qDpMSd21PTtCZ1vf5UovoDPg06icXI52ocY7GZSVuyfeDnIefkmCSU0aXmWHd_cOY_i5gpjkwkYDzikPYRUlrUWFa0YJy-jbLTrPryCt70O2NGtcTmrOaOYEz9TJP6i8OlhYk7-st7m_Izh-IhhAuTTE4FbJBh93wTdPwz6mfPi9DLRbwIwhxhF6aWxSa598BetyaLmeFPlnUmQuNpOStewv7YP9_1S_AQ5Gvc0
CitedBy_id crossref_primary_10_1044_2023_JSLHR_23_00577
crossref_primary_10_1044_2024_JSLHR_24_00283
crossref_primary_10_1111_ncn3_12849
crossref_primary_10_3390_brainsci15030271
crossref_primary_10_1016_j_cortex_2024_06_011
crossref_primary_10_1080_02687038_2024_2441203
crossref_primary_10_1016_j_cortex_2024_04_008
crossref_primary_10_61989_6kkkds06
crossref_primary_10_1044_2024_AJSLP_24_00104
crossref_primary_10_1044_2024_JSLHR_23_00007
crossref_primary_10_3233_ADR_230168
crossref_primary_10_1016_j_actpsy_2025_104781
crossref_primary_10_1016_j_nicl_2024_103639
crossref_primary_10_1080_17549507_2023_2263181
crossref_primary_10_1044_2024_PERSP_24_00002
crossref_primary_10_1093_brain_awae016
crossref_primary_10_1080_02687038_2025_2477014
crossref_primary_10_1080_02687038_2024_2322770
crossref_primary_10_3233_JAD_230912
crossref_primary_10_2490_jjrmc_61_942
crossref_primary_10_1016_j_prdoa_2023_100207
crossref_primary_10_1016_j_parkreldis_2024_107109
crossref_primary_10_1044_2023_AJSLP_23_00141
crossref_primary_10_1007_s10072_024_07758_4
crossref_primary_10_3390_brainsci14050417
crossref_primary_10_1044_2024_AJSLP_24_00013
crossref_primary_10_1080_17549507_2023_2221407
crossref_primary_10_1044_2023_AJSLP_22_00296
crossref_primary_10_1044_2023_AJSLP_22_00297
crossref_primary_10_2496_hbfr_44_156
crossref_primary_10_1044_2024_JSLHR_24_00049
crossref_primary_10_1044_2024_AJSLP_23_00424
crossref_primary_10_1007_s11910_023_01275_1
crossref_primary_10_1016_j_bandl_2023_105314
crossref_primary_10_1044_2023_PERSP_23_00043
crossref_primary_10_1093_braincomms_fcae113
Cites_doi 10.1093/brain/aws032
10.1016/j.jcomdis.2014.06.008
10.1159/000110176
10.1044/2020_AJSLP-20-00012
10.1044/2018_AJSLP-MSC18-18-0099
10.1080/02687038.2013.869307
10.1080/02687038.2020.1787732
10.1044/2015_AJSLP-14-0118
10.1016/j.bandc.2018.11.005
10.1016/j.cortex.2015.05.013
10.1044/2020_JSLHR-20-00445
10.1044/2015_AJSLP-14-0174
10.1212/WNL.0000000000000412
10.1080/02687030600597358
10.1212/WNL.0b013e31829c5ed5
10.1044/2018_AJSLP-17-0227
10.1093/brain/awu223
10.1044/2017_JSLHR-S-16-0443
10.1016/j.bandl.2017.01.012
10.1002/mds.26987
10.1016/j.bandl.2018.06.004
10.1044/2018_AJSLP-17-0186
10.1016/j.jcm.2016.02.012
10.1044/1092-4388(2012/11-0318)
10.18637/jss.v033.i01
10.1007/s00415-020-09883-4
10.1161/STROKEAHA.115.009211
10.1016/j.jcomdis.2020.106076
10.1080/13554794.2016.1172645
10.1044/2018_JSLHR-L-17-0474
10.1044/2020_JSLHR-20-00253
10.1016/j.neuropsychologia.2015.12.010
10.1044/2020_JSLHR-20-00061
10.1038/s41467-021-23687-8
10.1044/2020_AJSLP-20-00126
ContentType Journal Article
Copyright COPYRIGHT 2023 American Speech-Language-Hearing Association
Copyright © 2023 The Authors
Copyright_xml – notice: COPYRIGHT 2023 American Speech-Language-Hearing Association
– notice: Copyright © 2023 The Authors
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1044/2022_AJSLP-22-00148
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Languages & Literatures
Social Welfare & Social Work
EISSN 1558-9110
EndPage 491
ExternalDocumentID PMC10171845
A743250764
36630926
10_1044_2022_AJSLP_22_00148
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDCD NIH HHS
  grantid: R01 DC012519
– fundername: NIDCD NIH HHS
  grantid: R01 DC014942
– fundername: NINDS NIH HHS
  grantid: R01 NS089757
GroupedDBID -W8
.GO
0-V
04C
0R~
23M
36B
4.4
53G
5GY
6J9
6PF
7RV
7X7
85S
8A4
8FW
8R4
8R5
AAHSB
AAWTL
AAYXX
ABDBF
ABIVO
ACGFO
ACGOD
ACHQT
ACIHN
ACUHS
ADBBV
ADCBC
ADOJX
AEAQA
AENEX
AERSA
AFKRA
AHMBA
AIKWM
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALSLI
ARALO
AZQEC
BENPR
BKEYQ
BMSDO
BPHCQ
BVXVI
CITATION
CJNVE
CPGLG
CRLPW
CS3
EAD
EAP
EAS
EBD
EBS
ECE
ECF
ECT
EIHBH
EMK
ESX
F9R
FYUFA
H13
HCIFZ
HZ~
IAO
ICO
IHR
IHW
IN-
INH
INIJC
INR
IPY
ITC
M0P
M1P
M2M
M2P
M2Q
O9-
P2P
PCD
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
QF4
QM7
QN7
RWL
S0X
SJA
TAE
TN5
TWZ
UKHRP
WH7
WQ9
3V.
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c570t-639e295bbb4b7fe466ea24854b6b0d6bf0080146fc34188a7abe5465d0217d9f3
ISSN 1058-0360
1558-9110
IngestDate Thu Aug 21 18:36:03 EDT 2025
Fri Jul 11 03:48:34 EDT 2025
Wed Mar 19 01:31:01 EDT 2025
Sat Mar 08 18:24:54 EST 2025
Thu May 22 21:21:32 EDT 2025
Thu Jan 02 22:38:38 EST 2025
Tue Jul 01 02:46:59 EDT 2025
Thu Apr 24 22:59:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c570t-639e295bbb4b7fe466ea24854b6b0d6bf0080146fc34188a7abe5465d0217d9f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Editor-in-Chief: Katherine C. Hustad
Editor: Adam Buchwald
Disclosure: The authors have declared that no competing financial or nonfinancial interests existed at the time of publication.
ORCID 0000-0001-9519-1302
0000-0002-8074-6587
0000-0001-9697-0084
0000-0003-2930-8634
0000-0001-8206-3432
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC10171845
PMID 36630926
PQID 2765073213
PQPubID 23479
PageCount 23
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10171845
proquest_miscellaneous_2765073213
gale_infotracmisc_A743250764
gale_infotracacademiconefile_A743250764
gale_healthsolutions_A743250764
pubmed_primary_36630926
crossref_citationtrail_10_1044_2022_AJSLP_22_00148
crossref_primary_10_1044_2022_AJSLP_22_00148
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-03-01
PublicationDateYYYYMMDD 2023-03-01
PublicationDate_xml – month: 03
  year: 2023
  text: 2023-03-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle American journal of speech-language pathology
PublicationTitleAlternate Am J Speech Lang Pathol
PublicationYear 2023
Publisher American Speech-Language-Hearing Association
Publisher_xml – name: American Speech-Language-Hearing Association
References e_1_3_2_27_1
e_1_3_2_28_1
e_1_3_2_29_1
e_1_3_2_42_1
e_1_3_2_20_1
e_1_3_2_41_1
e_1_3_2_21_1
e_1_3_2_44_1
e_1_3_2_22_1
e_1_3_2_43_1
e_1_3_2_23_1
e_1_3_2_24_1
e_1_3_2_25_1
Clark H. M. (e_1_3_2_10_1) 2015
e_1_3_2_26_1
McNeil M. R. (e_1_3_2_32_1) 2017
e_1_3_2_40_1
Duffy J. R. (e_1_3_2_13_1) 2020
R Core Team (e_1_3_2_35_1) 2020
e_1_3_2_16_1
e_1_3_2_39_1
e_1_3_2_17_1
e_1_3_2_38_1
e_1_3_2_8_1
e_1_3_2_18_1
e_1_3_2_7_1
e_1_3_2_19_1
e_1_3_2_2_1
e_1_3_2_31_1
e_1_3_2_11_1
e_1_3_2_6_1
e_1_3_2_12_1
e_1_3_2_5_1
e_1_3_2_34_1
e_1_3_2_4_1
e_1_3_2_14_1
e_1_3_2_37_1
e_1_3_2_3_1
e_1_3_2_15_1
e_1_3_2_36_1
McNeil M. R. (e_1_3_2_33_1) 2009
Wambaugh J. L. (e_1_3_2_45_1) 2006; 14
Clark H. M. (e_1_3_2_9_1) 2016
Kertesz A. (e_1_3_2_30_1) 2006
References_xml – volume-title: Speech features unique to apraxia of speech: preliminary item analysis of the Apraxia of Speech Rating Scale (ASRS)
  year: 2015
  ident: e_1_3_2_10_1
– volume: 14
  start-page: xv
  issue: 2
  year: 2006
  ident: e_1_3_2_45_1
  article-title: Treatment guidelines for acquired apraxia of speech: A synthesis and evaluation of the evidence
  publication-title: Journal of Medical Speech-Language Pathology
– ident: e_1_3_2_29_1
  doi: 10.1093/brain/aws032
– ident: e_1_3_2_37_1
  doi: 10.1016/j.jcomdis.2014.06.008
– ident: e_1_3_2_23_1
  doi: 10.1159/000110176
– start-page: 195
  volume-title: Speech motor control in normal and disordered speech: Future developments in theory and methodology
  year: 2017
  ident: e_1_3_2_32_1
– ident: e_1_3_2_40_1
  doi: 10.1044/2020_AJSLP-20-00012
– ident: e_1_3_2_44_1
  doi: 10.1044/2018_AJSLP-MSC18-18-0099
– ident: e_1_3_2_16_1
  doi: 10.1080/02687038.2013.869307
– ident: e_1_3_2_17_1
  doi: 10.1080/02687038.2020.1787732
– ident: e_1_3_2_4_1
  doi: 10.1044/2015_AJSLP-14-0118
– ident: e_1_3_2_38_1
  doi: 10.1016/j.bandc.2018.11.005
– ident: e_1_3_2_8_1
  doi: 10.1016/j.cortex.2015.05.013
– ident: e_1_3_2_21_1
  doi: 10.1044/2020_JSLHR-20-00445
– volume-title: Western Aphasia Battery–Revised (WAB-R)
  year: 2006
  ident: e_1_3_2_30_1
– ident: e_1_3_2_19_1
– ident: e_1_3_2_15_1
  doi: 10.1044/2015_AJSLP-14-0174
– ident: e_1_3_2_7_1
  doi: 10.1212/WNL.0000000000000412
– volume-title: Revisions to the Apraxia of Speech Rating Scale [Paper presentation].
  year: 2016
  ident: e_1_3_2_9_1
– ident: e_1_3_2_12_1
  doi: 10.1080/02687030600597358
– start-page: 249
  volume-title: Clinical management of sensorimotor speech disorders
  year: 2009
  ident: e_1_3_2_33_1
– ident: e_1_3_2_28_1
  doi: 10.1212/WNL.0b013e31829c5ed5
– ident: e_1_3_2_41_1
  doi: 10.1044/2018_AJSLP-17-0227
– ident: e_1_3_2_27_1
  doi: 10.1093/brain/awu223
– ident: e_1_3_2_6_1
  doi: 10.1044/2017_JSLHR-S-16-0443
– ident: e_1_3_2_14_1
  doi: 10.1016/j.bandl.2017.01.012
– ident: e_1_3_2_24_1
  doi: 10.1002/mds.26987
– volume-title: R: A language and environment for statistical computing
  year: 2020
  ident: e_1_3_2_35_1
– ident: e_1_3_2_42_1
  doi: 10.1016/j.bandl.2018.06.004
– ident: e_1_3_2_22_1
  doi: 10.1044/2018_AJSLP-17-0186
– ident: e_1_3_2_31_1
  doi: 10.1016/j.jcm.2016.02.012
– ident: e_1_3_2_20_1
  doi: 10.1044/1092-4388(2012/11-0318)
– ident: e_1_3_2_18_1
  doi: 10.18637/jss.v033.i01
– ident: e_1_3_2_36_1
  doi: 10.1007/s00415-020-09883-4
– ident: e_1_3_2_5_1
  doi: 10.1161/STROKEAHA.115.009211
– ident: e_1_3_2_25_1
  doi: 10.1016/j.jcomdis.2020.106076
– volume-title: Motor speech disorders: Substrates, differential diagnosis, and management
  year: 2020
  ident: e_1_3_2_13_1
– ident: e_1_3_2_34_1
  doi: 10.1080/13554794.2016.1172645
– ident: e_1_3_2_39_1
  doi: 10.1044/2018_JSLHR-L-17-0474
– ident: e_1_3_2_43_1
  doi: 10.1044/2020_JSLHR-20-00253
– ident: e_1_3_2_3_1
  doi: 10.1016/j.neuropsychologia.2015.12.010
– ident: e_1_3_2_2_1
  doi: 10.1044/2020_JSLHR-20-00061
– ident: e_1_3_2_26_1
  doi: 10.1038/s41467-021-23687-8
– ident: e_1_3_2_11_1
  doi: 10.1044/2020_AJSLP-20-00126
SSID ssj0001122
Score 2.5006502
Snippet The purpose of this study was to examine the interrater reliability and validity of the Apraxia of Speech Rating Scale (ASRS-3.5) as an index of the presence...
Purpose: The purpose of this study was to examine the interrater reliability and validity of the Apraxia of Speech Rating Scale (ASRS-3.5) as an index of the...
Supplemental Material: https://doi.org/10.23641/asha.21817584
SourceID pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 469
SubjectTerms Aphasia
Aphasia - diagnosis
Apraxia
Apraxias - diagnosis
Dysarthria - diagnosis
Humans
Neurodegenerative Diseases
Reproducibility of Results
Speech
Title The Apraxia of Speech Rating Scale: Reliability, Validity, and Utility
URI https://www.ncbi.nlm.nih.gov/pubmed/36630926
https://www.proquest.com/docview/2765073213
https://pubmed.ncbi.nlm.nih.gov/PMC10171845
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiFeEBQYgQJGQvDQpqSJc-OtY1TT1CHUrbC3yHFstWJqq14k4OfwSzm-xEnGNDFeoih2ncv5-p1z7HOOEXqTEkILyoD9wMtxScECN_US4aYs9YEN_SBlKsr3c3Q8JScX4UWr9bsWtbTb5n3269q8kv-RKlwDucos2VtI1g4KF-Ac5AtHkDAc_1nGw9Wa_phTlXyy4pzNuhOqQpnPmAwV1vFuc12NW33Qr2B5F-ZczppPt6qpbqXaZZxaXYmNGtwt5zdlQdZZY0r-aCfEz2pRoTvpV7PdZakCFQ1ca1HRQVr7KUu0e2qbppJ6zKbaEyDk7rhfn6EAkdsQLUOqXijT-PS-AX1uiDZUROvVmbia6bQOsaZVordzMRqa6P29_iJ_jxCZ3wJWSTY8ORt_ccHPli5gUum6cn3_igq0gYlqSZ6QrBokgxM1yB2074MrAly6Pzw8OhxZfQ8Wq15TN29Z1rYi5P01z9Kwf65aATUzqBmiW7N5zh-g-8ZZwUONvIeoxRdtdDA2ENjgt3hsq3Jv2ujuqQnUaKOOTvvG3_iloGsOPcsLy_X3R2gEyMUGuXgpsEYu1sjFCrkfcA23PVyitocBs9hg9jGajj6dfzx2zY4eLgtjb-uCOcz9NMzznOSx4CSKOJU19Uge5V4R5UI6MKC7BQPjKkloTHMekigspOdcpCJ4gvYWywV_ijCJwc4aRDyOREFSzqgnwHfwfCpInDIROsgvv3PGTLl7uevKZXaDjB3Usz9a6WovN3d_JQWY6ZRlyyjZEMxycC3iiDjoneohcQp3Z9QkvcA7yLprjZ6dRk9gedZofl2CJJNNMjRywZe7TebH4GTFgT8IHHSgQWOfPQB_wkv9yEFJA062gywu32xZzGeqyLxU1YOEhM9u90meo3sVBXTQ3na94y_AbN_mL83_5g8LteNH
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Apraxia+of+Speech+Rating+Scale%3A+Reliability%2C+Validity%2C+and+Utility&rft.jtitle=American+journal+of+speech-language+pathology&rft.au=Duffy%2C+Joseph+R.&rft.au=Martin%2C+Peter+R.&rft.au=Clark%2C+Heather+M.&rft.au=Utianski%2C+Rene+L.&rft.date=2023-03-01&rft.issn=1058-0360&rft.eissn=1558-9110&rft.volume=32&rft.issue=2&rft.spage=469&rft.epage=491&rft_id=info:doi/10.1044%2F2022_AJSLP-22-00148&rft.externalDBID=n%2Fa&rft.externalDocID=10_1044_2022_AJSLP_22_00148
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1058-0360&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1058-0360&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1058-0360&client=summon